Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
454
Condiciones sociales
86
Condiciones económicas
85
Desarrollo de recursos hídricos
80
Política y gobierno
69
Indígenas de México
65
Aspectos sociales
62
Vida social y costumbres
60
Abastecimiento de agua
54
Novela española
54
Leyes y legislación
49
Crítica e interpretación
45
Historia y crítica
44
Educación
35
Cuentos uruguayos
34
Estudio y enseñanza
31
Filosofía
30
Aspectos económicos
29
Antigüedades
26
Administración municipal
24
Administración
23
Biografías
23
Otomíes
20
Descripciones y viajes
19
México
19
Política gubernamental
19
Agricultura
18
Aspectos políticos
18
Diagnóstico
18
Fuentes
18
-
9301por Terranova-Barberio, Manuela, Pecori, Biagio, Roca, Maria Serena, Imbimbo, Serena, Bruzzese, Francesca, Leone, Alessandra, Muto, Paolo, Delrio, Paolo, Avallone, Antonio, Budillon, Alfredo, Di Gennaro, Elena“…The present study examined the combination of the histone deacetylase inhibitor (HDACi) valproic acid (VPA) with fluoropyrimidine-based chemo-radiotherapy on colorectal cancer (CRC) cells. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9302por Patel, Nibedita, Garikapati, Koteswara Rao, Makani, Venkata Krishna Kanth, Nair, Ayikkara Drishya, Vangara, Namratha, Bhadra, Utpal, Pal Bhadra, Manika“…Here, we also report that miR-200a, miR-200b, miR-203 accretes the sensitivity of MDAMB-231 cells to the histone deacetylase inhibitor (HDACi) SAHA and miR-15a sensitized breast cancer cells to the chemotherapeutic drug cisplatin leading to apoptosis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9303“…We also describe the challenges leading to the lack of efficacy with ICI use and discuss potential strategies to overcome those challenges including: chimeric antigen receptor T-cell therapy (CAR-T therapy), bispecific T-cell therapy (BiTE), lymphocyte activation gene-3 (LAG-3) inhibitors, T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) inhibitors, vaccines, promotion of inflammatory macrophages, indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, DNA methyltransferase inhibitors (DNMTi) and histone deacetylase inhibitors (HDACi). Tumor mutational burden and interferon-gamma release assays are potential biomarkers of ICI treatment response beyond PD-L1 expression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9304por Han, Han, Feng, Xue, Guo, Yarui, Cheng, Meijia, Cui, Zhengguo, Guo, Shanchun, Zhou, Weiqiang“…Chidamide, a new chemically structured HDACi-like drug, has been shown to inhibit breast cancer, but its specific mechanism has not been fully elucidated. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9305por Ricciardi, Natalie R., Modarresi, Farzaneh, Lohse, Ines, Andrade, Nadja S., Newman, Ian R., Brown, Jonathan M., Borja, Caroline, Marples, Brian, Wahlestedt, Claes R., Volmar, Claude-Henry“…In the present study, we investigate the synergistic potential of using both RT and HDACi as a low-dose combination therapy (LDCT) to maximize disease modification (reduce neuroinflammation and amyloidogenic APP processing, increase neurotrophic gene expression) while minimizing the potential for treatment-associated side effects. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9306por Park, Chi-Hun, Jeong, Young Hee, Jeong, Yeun-Ik, Lee, Se-Yeong, Jeong, Yeon-Woo, Shin, Taeyoung, Kim, Nam-Hyung, Jeung, Eui-Bae, Hyun, Sang-Hwan, Lee, Chang-Kyu, Lee, Eunsong, Hwang, Woo Suk“…Aberrant expression patterns in cloned embryos of both sexes were not ameliorated by treatment with Scriptaid as a potent HDACi, although the blastocyst rate increased remarkably after this treatment. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9307por Scuto, A, Kirschbaum, M, Buettner, R, Kujawski, M, Cermak, J M, Atadja, P, Jove, R“…These data suggest that STAT3 is a corepressor with NF-κB of the GADD45G gene and provides in vitro proof-of-concept for the combination of HDACi with SIRT1 activators as a potential new therapeutic strategy in lymphoid malignancies.…”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9308por Farifteh, Fattaneh, Salehi, Mohammad, Bandehpour, Mojgan, Nariman, Mosaffa, Ghafari Novin, Marefat, Hosseini, Taher, Nematollahi, Sedigheh, Noroozian, Mohsen, Keshavarzi, Somayeh, Hosseini, Ahmad“…Trichostatin A (TSA) as a histone deacetylase in- hibitor (HDACi) plays an important role in the reorganization of the genome and epigenetic changes. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9309por Xu, Xing-dong, Yang, Lan, Zheng, Li-yun, Pan, Yan-yan, Cao, Zhi-fei, Zhang, Zhi-qing, Zhou, Quan-sheng, Yang, Bo, Cao, Cong“…RESULTS: Here, we reported that SAHA, a histone deacetylase inhibitor (HDACi), exerted significant inhibitory efficiency against pancreatic cancer cell survival, proliferation, migration and VM. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9310por Jeong, Yeon Ik, Park, Chi Hun, Kim, Huen Suk, Jeong, Yeon Woo, Lee, Jong Yun, Park, Sun Woo, Lee, Se Yeong, Hyun, Sang Hwan, Kim, Yeun Wook, Shin, Taeyoung, Hwang, Woo Suk“…Many different approaches have been developed to improve the efficiency of animal cloning by somatic cell nuclear transfer (SCNT), one of which is to modify histone acetylation levels using histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA). In the present study, we examined the effect of TSA on in vitro development of porcine embryos derived from SCNT. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9311“…METHODS: Therefore, HCC cell lines were treated with the histone deacetylase inhibitor (HDACi) trichostatin A and by siRNA-knockdown of HDAC1–3. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9312“…The aim of this study was to investigate the effect of sodium butyrate (NaB) as a histone deacetylase inhibitor (HDACi) on the expression of the HDAC8 gene in the colorectal cancer cell line, and the molecular docking of the LHX1 transcription factor with NaB. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9313por Bissonnette, Reid P., Cesario, Rosemary M., Goodenow, Bob, Shojaei, Farbod, Gillings, Mireille“…CONCLUSIONS: These findings suggest that HBI-8000 mediates epigenetic modifications in the tumor microenvironment, leading to improved efficacy of ICIs, and provide strong rationale for combination therapies with ICIs and HBI-8000 in the clinical setting. PRECIS: As an HDACi, HBI-8000 plays an important role in priming the immune system in the tumor microenvironment. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9314“…Development of safer drugs based on epigenetic modifiers, e.g., histone deacetylase inhibitors (HDACi), requires better understanding of their effects on cardiac electrophysiology. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9315por Chen, Shuo, Zhao, Yang, Gou, Wen-feng, Zhao, Shuang, Takano, Yasuo, Zheng, Hua-chuan“…Histone deacetylase inhibitors (HDACi), such as suberoylanilide hydroxamic acid (SAHA), have been shown to act selectively on gene expression, and are potent inducers of growth arrest, differentiation and apoptosis in various types of cancers in vitro and in vivo. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9316por Danaher, Robert J, Zhang, Liping, Donley, Connor J, Laungani, Nashwin A, Hui, S Elise, Miller, Craig S, Westlund, Karin N“…Remarkably, preemptive manipulation of gene expression with two HDAC inhibitors (HDACi's), suberanilohydroxamic acid (SAHA) and MS-275, reduces the magnitude and duration of whisker pad mechanical hypersensitivity and prevents the development of a persistent pain state. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9317por Niparuck, Pimjai, Limsuwanachot, Nittaya, Pukiat, Sulada, Chantrathammachart, Pichika, Rerkamnuaychoke, Budsaba, Magmuang, Sutada, Phusanti, Sithakom, Boonyawat, Kochawan, Puavilai, Teeraya, Angchaisuksiri, Pantep, Ungkanont, Artit, Chuncharunee, Suporn“…METHODS: We recruited 141 consecutive AML patients during January 2010–June 2017, the patients received induction chemotherapy with standard dose Ara-C and Idarubicin (7 + 3 or 5 + 2 regimen) followed by intermediate (IDAC) or high dose Ara-c (HiDAC) consolidation therapy. RESULTS: Normal karyotype, complex, favorable, intermediate and adverse chromosomal aberrations were found in 59%, 16%, 5%, 14% and 6%, respectively. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9318“…Here, we characterized these pathways in AML patients enrolled in a phase I dose escalation trial that combined Selinexor, a Selective Inhibitor of Nuclear Export (SINE), with high-dose cytarabine (HiDAC) and mitoxantrone (Mito) (NCT02573363) as induction therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9319por Ye, Tian, Wei, Liwen, Shi, Ji, Jiang, Ke, Xu, Huizhe, Hu, Lulu, Kong, Lingkai, Zhang, Ye, Meng, Songshu, Piao, Haozhe“…Histone deacetylase inhibitors (HDACi) have demonstrated clinical and preclinical activities against GBM. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9320por Al-Sanea, Mohammad M, Gotina, Lizaveta, Mohamed, Mamdouh FA, Grace Thomas Parambi, Della, Gomaa, Hesham A M, Mathew, Bijo, Youssif, Bahaa G M, Alharbi, Khalid Saad, Elsayed, Zainab M, Abdelgawad, Mohamed A, Eldehna, Wagdy M“…Collectively, these results suggest that 7a merits further optimization and development as an effective new HDACI lead compound.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto